Literature DB >> 18093235

Heteroresistance: a concern of increasing clinical significance?

M E Falagas, G C Makris, G Dimopoulos, D K Matthaiou.   

Abstract

Recent studies have focused on issues related to heteroresistance, including its definition, methods of detection and frequency. Most such studies have reported data concerning infections caused by Staphylococcus aureus, but the clinical significance of heteroresistance is unclear. Six studies have described infections caused by S. aureus strains that were heteroresistant to vancomycin, with two suggesting an association between the emergence of heteroresistance and treatment failure or mortality, and four suggesting no such association. Further studies are required to evaluate the clinical implications of heteroresistance in an era in which rates of antimicrobial resistance are increasing alarmingly worldwide.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18093235     DOI: 10.1111/j.1469-0691.2007.01912.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  42 in total

1.  Screening for Intermediately Vancomycin-Susceptible and Vancomycin-Heteroresistant Staphylococcus aureus by Use of Vancomycin-Supplemented Brain Heart Infusion Agar Biplates: Defining Growth Interpretation Criteria Based on Gold Standard Confirmation.

Authors:  Riad Khatib; Kathleen Riederer; Mamta Sharma; Stephen Shemes; Sugantha P Iyer; Susan Szpunar
Journal:  J Clin Microbiol       Date:  2015-08-26       Impact factor: 5.948

2.  Detection of intermediately vancomycin-susceptible and heterogeneous Staphylococcus aureus isolates: comparison of Etest and Agar screening methods.

Authors:  K Riederer; S Shemes; P Chase; A Musta; A Mar; R Khatib
Journal:  J Clin Microbiol       Date:  2011-04-13       Impact factor: 5.948

Review 3.  Antimicrobial heteroresistance: an emerging field in need of clarity.

Authors:  Omar M El-Halfawy; Miguel A Valvano
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

4.  Rapid induction of high-level carbapenem resistance in heteroresistant KPC-producing Klebsiella pneumoniae.

Authors:  Sheila Adams-Sapper; Shantell Nolen; Grace Fox Donzelli; Mallika Lal; Kunihiko Chen; Livia Helena Justo da Silva; Beatriz M Moreira; Lee W Riley
Journal:  Antimicrob Agents Chemother       Date:  2015-03-23       Impact factor: 5.191

Review 5.  Antimicrobial Susceptibility Testing for Polymyxins: Challenges, Issues, and Recommendations.

Authors:  Fereshteh Ezadi; Abdollah Ardebili; Reza Mirnejad
Journal:  J Clin Microbiol       Date:  2019-03-28       Impact factor: 5.948

6.  Deciphering Heteroresistance to Colistin in a Klebsiella pneumoniae Isolate from Marseille, France.

Authors:  Lucie Bardet; Sophie Baron; Thongpan Leangapichart; Liliane Okdah; Seydina M Diene; Jean-Marc Rolain
Journal:  Antimicrob Agents Chemother       Date:  2017-05-24       Impact factor: 5.191

7.  A comparison of Sensititre™ Anaerobe MIC plate with ATB ANA® test for the routine susceptibility testing of common anaerobe pathogens.

Authors:  Abdessalam Cherkaoui; Adrien Fischer; Nouria Azam; Arnaud Riat; Jacques Schrenzel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-09-06       Impact factor: 3.267

8.  Rapid Whole-Genome Sequencing of Mycobacterium tuberculosis Isolates Directly from Clinical Samples.

Authors:  Amanda C Brown; Josephine M Bryant; Katja Einer-Jensen; Jolyon Holdstock; Darren T Houniet; Jacqueline Z M Chan; Daniel P Depledge; Vladyslav Nikolayevskyy; Agnieszka Broda; Madeline J Stone; Mette T Christiansen; Rachel Williams; Michael B McAndrew; Helena Tutill; Julianne Brown; Mark Melzer; Caryn Rosmarin; Timothy D McHugh; Robert J Shorten; Francis Drobniewski; Graham Speight; Judith Breuer
Journal:  J Clin Microbiol       Date:  2015-05-13       Impact factor: 5.948

9.  Colistin heteroresistance in Enterobacter cloacae is associated with cross-resistance to the host antimicrobial lysozyme.

Authors:  Brooke A Napier; Victor Band; Eileen M Burd; David S Weiss
Journal:  Antimicrob Agents Chemother       Date:  2014-06-30       Impact factor: 5.191

10.  Expansion and evolution of a virulent, extensively drug-resistant (polymyxin B-resistant), QnrS1-, CTX-M-2-, and KPC-2-producing Klebsiella pneumoniae ST11 international high-risk clone.

Authors:  Leonardo Neves Andrade; Lúcia Vitali; Gilberto Gambero Gaspar; Fernando Bellissimo-Rodrigues; Roberto Martinez; Ana Lúcia Costa Darini
Journal:  J Clin Microbiol       Date:  2014-05-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.